Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Morgan

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Therapeutics|June 1, 1994
Application of a Stable Isotope Technique for the Bioequivalency Study of Two Transdermal Nitroglycerin SystemsJim X. Sun, Anthony J. Piraino, John M. Morgan, et al.
Open Heart|October 14, 2024
Predictors of death without prior appropriate therapy in ICD recipients: the comorbidities, frailty and functional status (COMFFORT study)David G Wilson, Archana Sharma-Oates, James Sheldon, et al.
Preventive Cardiology|November 13, 2004
Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemiaDavid M Capuzzi, John M Morgan, Christina M Carey, et al.
Journal of Cardiovascular Electrophysiology|December 6, 2012
Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR studyPaul A Scott, James A Rosengarten, David C Murday, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 16, 2022
Role of deep learning methods in screening for subcutaneous implantable cardioverter defibrillator in heart failureMohamed ElRefai, Mohamed Abouelasaad, Benedict M Wiles, et al.
The American Journal of Cardiology|June 14, 2008
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarctionZongliang Lu, Wenrong Kou, Baomin Du, et al.
Journal of Clinical Pathology|September 12, 2006
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.
International Journal of Cardiology|March 27, 2018
Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC studyMauro Biffi, Pascal Defaye, Pierre Jaïs, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 26, 2011
Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkersPaul A Scott, Paul A Townsend, Leong L Ng, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 21, 2007
Non-contact mapping guided cardiac resynchronization therapy for a failing systemic right ventricleKevin A Michael, Gruschen R Veldtman, John R Paisey, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Therapeutics|June 1, 1994
Application of a Stable Isotope Technique for the Bioequivalency Study of Two Transdermal Nitroglycerin SystemsJim X. Sun, Anthony J. Piraino, John M. Morgan, et al.
Open Heart|October 14, 2024
Predictors of death without prior appropriate therapy in ICD recipients: the comorbidities, frailty and functional status (COMFFORT study)David G Wilson, Archana Sharma-Oates, James Sheldon, et al.
Preventive Cardiology|November 13, 2004
Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemiaDavid M Capuzzi, John M Morgan, Christina M Carey, et al.
Journal of Cardiovascular Electrophysiology|December 6, 2012
Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR studyPaul A Scott, James A Rosengarten, David C Murday, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 16, 2022
Role of deep learning methods in screening for subcutaneous implantable cardioverter defibrillator in heart failureMohamed ElRefai, Mohamed Abouelasaad, Benedict M Wiles, et al.
The American Journal of Cardiology|June 14, 2008
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarctionZongliang Lu, Wenrong Kou, Baomin Du, et al.
Journal of Clinical Pathology|September 12, 2006
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.
International Journal of Cardiology|March 27, 2018
Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC studyMauro Biffi, Pascal Defaye, Pierre Jaïs, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 26, 2011
Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkersPaul A Scott, Paul A Townsend, Leong L Ng, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 21, 2007
Non-contact mapping guided cardiac resynchronization therapy for a failing systemic right ventricleKevin A Michael, Gruschen R Veldtman, John R Paisey, et al.
Pageof 10